Silvia Olivera-Bravo

Dr. Silvia Olivera-Bravo


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
Emiliano TriasEmiliano Trias
Emiliano Trias
PDPablo Díaz-Amarilla
Pablo Díaz-Amarilla
SOSilvia Olivera-Bravo
Silvia Olivera-Bravo
EIEugenia Isasi
Eugenia Isasi
DDDerek A. Drechsel
Derek A. Drechsel
LBLuis Barbeito
Luis Barbeito
Microglia and reactive astrocytes accumulate in the spinal cord of rats expressing the ALS-linked SOD1G93A mutation. We previously reported that the rapid progression of paralysis in ALS rats is associated with the appearance of proliferative astrocyte-like cells thatsurroundmotor neurons. These cells, designated as Aberrant Astrocytes (AbA cells) because of their atypical astrocytic phenotype, exhibit high toxicity to motor neurons. However, the cellular origin of AbA cells remains unknown. Because AbA cells are labeled with the proliferation marker Ki67, we analyzed the phenotypic makers of proliferating glial cells that surround motor neurons by immunohistochemistry. The number of Ki67+AbA cells sharply increased in symptomatic rats, displaying large cell bodies with processes embracing motor neurons. Most were co-labeled with astrocytic marker GFAP concurrently with the microglial markers Iba1 and CD163. Cultures of spinal cord prepared from symptomatic SOD1G93A rats yielded large numbers of microglia expressing Iba1, CD11b and CD68. Cells sortedfor CD11b expression by flow cytometry transformed into AbA cells within two weeks. During these two weeks, the expression of microglial markers largely disappeared, while GFAP and S100β expression increased. The phenotypic transition to AbA cells was stimulated by forskolin. These findings provide evidence for a subpopulation of proliferating microglial cells in SOD1G93A rats that undergo a phenotypic transition into AbA cells after onset of paralysis that may promote the fulminant disease progression. These cells could be a therapeutic target for slowing paralysis progression in ALS.

2 September 2017 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
MJMarcie Jiménez-Riani
Marcie Jiménez-Riani
PDPablo Díaz-Amarilla
Pablo Díaz-Amarilla
EIEugenia Isasi
Eugenia Isasi
GCGabriela Casanova
Gabriela Casanova
LBLuis Barbeito
Luis Barbeito
SOSilvia Olivera-Bravo
Silvia Olivera-Bravo

24 July 2014 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
EIEugenia Isasi
Eugenia Isasi
LBLuis Barbeito
Luis Barbeito
SOSilvia Olivera-Bravo
Silvia Olivera-Bravo
Glutaric acid (GA) is a dicarboxylic acid that accumulates in millimolar concentrations in glutaric acidemia I (GA-I), an inherited neurometabolic childhood disease characterized by extensive neurodegeneration. Vascular dysfunction is a common and early pathological feature in GA-I, although the underlying mechanisms remain unknown. In the present study, we have used a previously-validated rat model of GA-I to determine the effect of GA on the blood- brain barrier (BBB) and the neurovascular unit.

24 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
GPGiselle Prunell
Giselle Prunell
SOSilvia Olivera-Bravo
Silvia Olivera-Bravo
Parkinson’s disease (PD) is an incurable neurodegenerative disease of high prevalence, characterized by the prominent death of dopaminergic neurons in the substantia nigra pars compacta, which produces dopamine deficiency, leading to classic motor symptoms. Although PD has traditionally been considered as a neuronal cell autonomous pathology, in which the damage of vulnerable neurons is responsible for the disease, growing evidence strongly suggests that astrocytes might have an active role in the neurodegeneration observed. In the present review, we discuss several studies evidencing astrocyte implications in PD, highlighting the consequences of both the loss of normal homeostatic functions and the gain in toxic functions for the wellbeing of dopaminergic neurons. The revised information provides significant evidence that allows astrocytes to be positioned as crucial players in PD etiology, a factor that needs to be taken into account when considering therapeutic targets for the treatment of the disease.

18 May 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
EIEugenia Isasi
Eugenia Isasi
NKNils Korte
Nils Korte
VAVerónica Abudara
Verónica Abudara
DADavid Attwell
David Attwell
SOSilvia Olivera-Bravo
Silvia Olivera-Bravo

7 October 2016
Verified
Book Chapter
Closed access
PDF file
SOSilvia Olivera-Bravo
Silvia Olivera-Bravo
EIEugenia Isasi
Eugenia Isasi
AFAnabel Fernández
Anabel Fernández
GCGabriela Casanova
Gabriela Casanova
JRJuan Carlos Rosillo
Juan Carlos Rosillo
LBLuigi Barbeito
Luigi Barbeito